Impact of Physical Activity During Pregnancy on Cardiac Variability in Newborns
NCT ID: NCT07264400
Last Updated: 2025-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2025-10-15
2029-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Monitored Effects of Physical Activity on Fetal Heart Rate by Using a Wireless Non-invasive Device
NCT06813859
Fetal Cardiovascular Response to Maternal Exercise During Third Trimester
NCT01723293
Evaluation of the Heart's Respiratory Quotient as Predictive Value After Extra-hospital Cardiac Arrest
NCT04211207
Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely
NCT02780908
Effectiveness of Volume Spirometry and Deep Breathing Exercise for Dyspnea During Third Trimester of Pregnancy
NCT04994028
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Assessment of cardiorespiratory function
A Holter ECG and oximetry recording will be performed on the child's second night for a minimum of 6 hours. Three electrodes will be placed on the newborn's chest, along with a pulse oximeter, and removed the following day.
Parents will be contacted by email at the child's second birthday to obtain information on their child's height and weight growth, and their neurodevelopment will be assessed using the Age and Stage Questionnaire (ASQ-3) at 24 months.
Heart rate variability
A Holter ECG recording will be performed on the child's second night for a minimum of 6 hours.
Pulmonary function
Oximetry recording will be performed on the child's second night for a minimum of 6 hours.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Heart rate variability
A Holter ECG recording will be performed on the child's second night for a minimum of 6 hours.
Pulmonary function
Oximetry recording will be performed on the child's second night for a minimum of 6 hours.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* born at the Clermont Ferrand University Hospital and after parental agreement for their child to participate may be included.
Exclusion Criteria
* making heart rate variability analysis impossible,
* having received invasive ventilatory support that does not allow analysis of the oximetry recording.
* Parental refusal or inability of parents to give their consent for their child to participate.
1 Day
3 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Justine Paysal
Role: PRINCIPAL_INVESTIGATOR
CHU de Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Clermont-Ferrand
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-A00329-40
Identifier Type: OTHER
Identifier Source: secondary_id
RBHP 2025 PAYSAL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.